ScienceDex / Researcher record
Vassiliki A Boussiotis
- Beth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,917,946 | 3 | #5,771 |
| 2025 | $2,892,060 | 4 | #3,626 |
| 2026 | $2,865,260 | 4 | #6,587 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY2025 · selected4 records
- FY20264 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2206318Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-3963-1518Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2025 award records by amount
NIH award records listing Vassiliki A Boussiotis as a PI. Multi-PI records show the full award amount for context.
- 1R35CA294015-01A1R35Contact PINavigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint ImmunotherapyBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$847Kaward amount
- 5R01CA257672-03R01Contact PIDetection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapyBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$709.4Kaward amount
- 1R01NS139479-01A1R01Co-investigatorDissecting Orchestrated Immune Responses to Glioblastoma within the Native Tissue Microenvironment to Improve Treatment OutcomesBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$687.3Kaward amount
- 5R01CA271601-03R01Co-investigatorUnderstanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.Beth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$648.4Kaward amount
Award organization
Organizations that administered FY2025 awards listing Vassiliki A Boussiotis as a PI.
FY2025 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBeth Israel Deaconess Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5771
- 2025$2M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #3626
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Vassiliki A Boussiotis.